Psoriasis-Liver-Methotrexate Interactions

Archives of Dermatology

Volumn 108, Issue 1, 1973, Pages 36-42

  Weinstein, G ^a   Roenigk, H ^b   Maibach, H ^c   Cosmides, J ^a   Halprin, K ^a   Millard, M ^a   Almeyda, J ^d   Auerbach, R ^e   Tobias, H ^e   Bergfeld, W ^b   Clyde, D ^f   Dahl, M ^g   Frost, P ^a   Schiff, E ^a   Krueger, R ^h   Tindall, J ^h   Lee, J ^c   Lundquist, A ⁱ   Schaffner, F ^j   Scheuer, P ^k   Zachariae, H ^l   more..

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ROYAL LONDON HOSPITAL   (United Kingdom)

^e NEW YORK UNIVERSITY   (United States)

^f Clyde Computing Service ^*  (United States)

^g ROYAL VICTORIA INFIRMARY   (United Kingdom)

^h DUKE UNIVERSITY   (United States)

ⁱ LUND UNIVERSITY   (Sweden)

^j MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^k ROYAL FREE HOSPITAL   (United Kingdom)

^l AARHUS UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84948007868     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1973.01620220008002     Document Type: Article

References (32)

1. Rees RB, et al: Methotrexate for psoriasis. Arch Dermatol 95:2-11, 1967.
2. Van Scott EJ, Auerbach R, Weinstein GD: Parenteral methotrexate in psoriasis. Arch Dermatol 89:550-556, 1964.
3. Roenigk HH Jr, Bergfeld WF, Curtis GH: Methotrexate for psoriasis in weekly oral doses. Arch Dermatol 99:86-93, 1969.
4. Weinstein GD, Frost P: Methotrexate for psoriasis: A new therapeutic schedule. Arch Dermatol 103:33-38, 1971.
5. Colsky J, Greenspan EM, Warren TN: Hepatic fibrosis in children with acute leukemia after therapy with folic acid antagonists. Arch Pathol 59:198-206, 1955.
6. Ryan TJ, et al: The treatment of psoriasis with folic acid antagonists. Br J Dermatol 76: 555-564, 1964.
7. Coe RO, Bull FE: Cirrhosis associated with methotrexate treatment of psoriasis. JAMA 206: 1515-1520, 1968.
8. Epstein EH, Croft JD Jr: Cirrhosis following methotrexate administration for psoriasis. Arch Dermatol 100:531-534, 1969.
9. Muller SA, Farrow GM, Martalock DL: Cirrhosis caused by methotrexate in the treatment of psoriasis. Arch Dermatol 100:523-530, 1969.
10. Dahl MGC, Gregory MM, Scheuer PJ: Liver damage due to methotrexate in patients with psoriasis. Br Med J 1:625-630, 1971.
11. Zachariae H, Schidt T: Liver biopsy in methotrexate treatment. Acta Derm Venerol 51: 215-220, 1971.
12. Roenigk HH Jr, et al: Hepatotoxicity of methotrexate in the treatment of psoriasis. Arch Dermatol 103:250-261, 1971.
13. Weinstein GD, et al: Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis. Arch Dermatol 102:613-618, 1970.
14. Berge G, et al: Liver biopsy in psoriasis. Br J Dermatol 82:250-253, 1970.
15. Hersh EM, et al: Hepatotoxic effects of methotrexate. Cancer 19:600-606, 1966.
16. Vogler WR, Huguley CM, Kerr W: Toxicity and antitumor effect of divided doses of methotrexate. Arch Intern Med 115:285-293, 1965.
17. Baker H: Psoriasis, methotrexate, and the liver, in Farber E, Cox A (eds): Psoriasis. Stanford, Calif, Stanford University Press, 1971, pp 409-416.
18. Hammond RE, Dawson PJ, Lobitz WC: Liver histology related to methotrexate therapy in psoriasis, in Farber E, Cox A (eds): Psoriasis. Stanford, Stanford University Press, 1971, pp 417-427.
19. Tindall JP, Callaway JL: Psoriasis and methotrexate with relation to the liver, in Farber E, Cox A (eds): Psoriasis. Stanford, Calif, Stanford University Press, 1971, pp 441-450.
20. Halprin KM, Fukui K, Ohkawara A: Blood levels of methotrexate and the treatment ofpsoriasis. Arch Dermatol 103:243-249, 1971.
21. McDonald CJ, Bertino JR: Parenteral methotrexate for psoriasis. Lancet 1:864, 1968.
22. Klatskin G: Experimental studies on the role of alcohol in the pathogenesis of cirrhosis. Am J Clin Nutr 9:439-443, 1961.
23. Isselbacher KJ, Greenberger NJ: Metabolic effects of alcohol on the liver. N Engl J Med 270:351, 402, 1964.
24. Lieber CS, Jones DP, DeCarli LM: Effects of prolonged ethanol intake: Production of fatty liver despite adequate diets. J Clin Invest 44: 1009-1021, 1965.
25. Westwater JO, Fainer D: Liver impairment in the obese. Gastroenterology 34:686-693, 1958.
26. Kalk H: The relationship between fatty liver and diabetes mellitus. Ger Med Mon 5:81-84, 1960.
27. Leevy CM, Ryan CM, Fineberg JC: Diabetes mellitus and liver dysfunction. Am J Med 8: 290-299, 1950.
28. Rubin E, Lieber CS: Alcohol-induced hepatic injury in nonalcoholic volunteers. N Engl J Med 278:869-876, 1968.
29. Kirshbaum JC, Shure N: Alcoholic cirrhosis of the liver. J Lab Clin Med 28:721-731, 1943.
30. Hall EM, Olsen AY, Davis FE: Portal cirrhosis. Am J Pathol 29:993-1022, 1953.
31. Holzner H, Rissel E, Springer K: Cirrhosis of the liver. Ger Med Mon 1:92-95, 1956.
32. Borner P: Cirrhosis of the liver. Ger Med Mon 6:115-118, 1961.